50090-6413-2 |
50090-6413 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20230328 |
N/A |
ANDA |
ANDA215562 |
A-S Medication Solutions |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
5 mg/1; 6.25 mg/1 |
90 TABLET in 1 BOTTLE (50090-6413-2) |
50090-6413-0 |
50090-6413 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20230328 |
N/A |
ANDA |
ANDA215562 |
A-S Medication Solutions |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
5 mg/1; 6.25 mg/1 |
30 TABLET in 1 BOTTLE (50090-6413-0) |
70518-4015-0 |
70518-4015 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20240207 |
N/A |
ANDA |
ANDA215562 |
REMEDYREPACK INC. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
2.5 mg/1; 6.25 mg/1 |
90 TABLET in 1 BOTTLE, PLASTIC (70518-4015-0) |
70954-412-10 |
70954-412 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20211104 |
N/A |
ANDA |
ANDA215562 |
ANI Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
2.5 mg/1; 6.25 mg/1 |
30 TABLET in 1 BOTTLE (70954-412-10) |
70954-413-30 |
70954-413 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20211104 |
N/A |
ANDA |
ANDA215562 |
ANI Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
5 mg/1; 6.25 mg/1 |
100 TABLET in 1 BOTTLE (70954-413-30) |
70954-413-40 |
70954-413 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20211104 |
N/A |
ANDA |
ANDA215562 |
ANI Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
5 mg/1; 6.25 mg/1 |
500 TABLET in 1 BOTTLE (70954-413-40) |
70954-414-10 |
70954-414 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20211104 |
N/A |
ANDA |
ANDA215562 |
ANI Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
10 mg/1; 6.25 mg/1 |
30 TABLET in 1 BOTTLE (70954-414-10) |
70954-414-30 |
70954-414 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20211104 |
N/A |
ANDA |
ANDA215562 |
ANI Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
10 mg/1; 6.25 mg/1 |
100 TABLET in 1 BOTTLE (70954-414-30) |
70954-414-40 |
70954-414 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20211104 |
N/A |
ANDA |
ANDA215562 |
ANI Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
10 mg/1; 6.25 mg/1 |
500 TABLET in 1 BOTTLE (70954-414-40) |
70954-412-30 |
70954-412 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20211104 |
N/A |
ANDA |
ANDA215562 |
ANI Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
2.5 mg/1; 6.25 mg/1 |
100 TABLET in 1 BOTTLE (70954-412-30) |
70954-412-40 |
70954-412 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20211104 |
N/A |
ANDA |
ANDA215562 |
ANI Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
2.5 mg/1; 6.25 mg/1 |
500 TABLET in 1 BOTTLE (70954-412-40) |
70954-413-10 |
70954-413 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20211104 |
N/A |
ANDA |
ANDA215562 |
ANI Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
5 mg/1; 6.25 mg/1 |
30 TABLET in 1 BOTTLE (70954-413-10) |
10135-740-01 |
10135-740 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20220501 |
N/A |
ANDA |
ANDA215562 |
Marlex Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
2.5 mg/1; 6.25 mg/1 |
100 TABLET in 1 BOTTLE (10135-740-01) |
10135-742-05 |
10135-742 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20220501 |
N/A |
ANDA |
ANDA215562 |
Marlex Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
10 mg/1; 6.25 mg/1 |
500 TABLET in 1 BOTTLE (10135-742-05) |
10135-742-30 |
10135-742 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20220501 |
N/A |
ANDA |
ANDA215562 |
Marlex Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
10 mg/1; 6.25 mg/1 |
30 TABLET in 1 BOTTLE (10135-742-30) |
10135-740-05 |
10135-740 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20220501 |
N/A |
ANDA |
ANDA215562 |
Marlex Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
2.5 mg/1; 6.25 mg/1 |
500 TABLET in 1 BOTTLE (10135-740-05) |
10135-741-01 |
10135-741 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20220501 |
N/A |
ANDA |
ANDA215562 |
Marlex Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
5 mg/1; 6.25 mg/1 |
100 TABLET in 1 BOTTLE (10135-741-01) |
10135-741-05 |
10135-741 |
HUMAN PRESCRIPTION DRUG |
Bisoprolol Fumarate and Hydrochlorothiazide |
Bisoprolol Fumarate and Hydrochlorothiazide |
TABLET |
ORAL |
20220501 |
N/A |
ANDA |
ANDA215562 |
Marlex Pharmaceuticals, Inc. |
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
5 mg/1; 6.25 mg/1 |
500 TABLET in 1 BOTTLE (10135-741-05) |